Although the exact underlying mechanism of how DNAJB protein is involved in cancer development and metastasis needs further investigation, the development of novel therapeutics or combining chemotherapeutic agents with other HSP40 inhibitors can be applied to show synergistic anticancer effects against DNAJB proteins [69,108,109,110,111,112,113,114]. The gene discussed is DNAJB1; the disease is cancer.